In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

Investing.com -- PTC Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) for the ...

We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Mesoblast Limited stands tenth on our ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift $203 million raising.

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...